Invex Therapeutics Ltd carries a market capitalization of 8.27M, placing it among publicly traded companies globally.
| Market Cap | 8.27M |
| Enterprise Value | N/A |
Invex Therapeutics Ltd's stock has gained approximately 18.27957% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | 18.27957% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |